Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery

Clinical Genitourinary Cancer

Volumn 5, Issue 5, 2007, Pages 334-337

  Teh, Bin S ^a   Bloch, Charles ^a   Paulino, Arnold C ^a   Shen, Steven ^a   Hinckley, Lisa ^a   Baskin, David ^a   Butler, Edward B ^a   Amato, Robert ^a  

^a HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

Kidney cancer; Radiation resistance; Radiation therapy

Indexed keywords

INTERLEUKIN 2; STEROID; THALIDOMIDE;

ADULT; ARTICLE; BRAIN METASTASIS; CANCER RADIOTHERAPY; CANCER SURGERY; CASE REPORT; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; LUNG METASTASIS; MALE; NEPHRECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIATION DOSE; RADIOSURGERY; STEREOTAXIC SURGERY; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 34547961148     PISSN: 15587673     EISSN: None     Source Type: Journal    
DOI: 10.3816/CGC.2007.n.013     Document Type: Article

References (20)

1. DiBiase SJ, Valicenti RK, Schultz D, et al. Palliative irradiation for focally symptomatic metastatic renal cell carcinoma: support for dose escalation based on a biological model. J Urol 1997; 158:746-749.
2. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin 2007; 57:43-66.
3. Whang Y, Godley P. Renal cell carcinoma. Curr Opin Oncol 2003; 15:213-216.
4. Sheehan JP, Sun MH, Kondziolka D, et al. Radiosurgery in patiens with renal cell carcinoma metastasis to the brain: long-term outcomes and prognostic factors influencing survival and local tumor control. J Neurosurg 2003; 98:342-349.
5. Decker DA, Decker VL, Herskovic A, et al. Brain metastases in patients with renal cell carcinoma: prognosis and treatment. J Clin Oncol 1984; 2:169-173.
6. Doh LS, Amato RJ, Paulino AC, et al. Radiation therapy in the management of brain metastases from renal cell carcinoma. Oncology (Williston Park) 2006; 20:603-613; discussion 613, 616, 619-620 passsim.
7. Wei K, Wandl E, Kärcher KH. X-ray induced DNA double-strand breakage and rejoining in a radiosensitive human renal cell carcinoma line estimated by CHEF electrophoresis. Strahlenther Onkol 1993; 169:740-744.
8. Ning S, Trisler K, Wessels BW, et al. Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in vitro and in vivo in human renal cell carcinoma xenografts. Cancer 1997; 80:2519-2528.
9. Syljuasen RG, Belldegrun A, Tso CL. Sensitization of renal carcinoma to radiation using alphainterferon (IFNA) gene transfection. Radiat Res 1997; 148:443-448.
10. Wilson D, Hiller L, Gray L, et al. The effect of biologicial effective dose on time to symptom progression in metastatic renal cell carcinoma. Clin Oncol 2003; 15:400-407.
11. Hernandez L, Zamorano L, Sloan A, et al. Gamma knife radiosurgery for renal cell carcinoma brain metastases. J Neurosurg 2002; 97:489-493.
12. Brown PD, Brown CA, Pollock BE, et al. Stereotactic radiosurgery for patients with "radioresistant" brain metastases. Neurosurgery 2002; 51:656-667.
13. Hoshi S, Jokura H, Nakamura H, et al. Gamma-knife radiosurgery for brain metastasis of renal cell carcinoma: results in 42 patients. Int J Urol 2002; 9:618-625; discussion 626.
14. Noel G, Valery CA, Boisserie G, et al. INAC radiosurgery for brain metastasis of renal cell carcinoma. Urol Onc 2004; 22:25-31.
15. Potters L, Steinberg M, Rose C, et al. American Society for Therapeutic Radiology and Oncology and American College of Radiology practice guideline for the performance of stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 2004; 60:1026-1032.
16. Wersall PJ, Blomgren H, Lax I, et al. Extracranial stereotactic radiotherapy for primary and metastatic renal cell carcinoma. Radiother Oncol 2005; 77:88-95.
17. Beitler JJ, Makara D, Silverman P, et al. Definitive, high-dose-per-fraction, conformal, stereotactic external radiation for renal cell carcinoma. Am J Clin Oncol 2004; 27:646-648.
18. Gerszten PC, Burton SA, Ozhasoglu C, et al. Stereotactic radiosurgery for spinal metastases from renal cell carcinoma. J Neurosurg Spine 2005; 3:288-295.
19. Kavanagh BD, Timmerman R. On the estimation of required doses in stereotactic body radiation therapy. In: Kavanagh BD, Timmerman R, eds. Stereotactic Body Radiation Therapy. Philadelphia, PA: Lippincott, Williams, and Wilkins; 2005.
20. Doh L, Curtis A, Teh BS. Renal-cell carcinoma. N Engl J Med 2006; 354:1095-1096.